Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Ryan, ET; Calderwood, SB
   Cholera vaccines
   JOURNAL OF TRAVEL MEDICINE
   
   E.T. Ryan e S.B. Calderwood, "Cholera vaccines", J TRAVEL M, 8(2), 2001, pp. 82-91
2. Leder, K; Weller, PF; Wilson, ME
   Travel vaccines and elderly persons: Review of vaccines available in the United States
   CLINICAL INFECTIOUS DISEASES
   
   K. Leder et al., "Travel vaccines and elderly persons: Review of vaccines available in the United States", CLIN INF D, 33(9), 2001, pp. 1553-1566
3. Allen, JS; Dougan, G; Strugnell, RA
   Kinetics of the mucosal antibody secreting cell response and evidence of specific lymphocyte migration to the lung after oral immunisation with attenuated S-enterica var. typhimurium
   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
   
   J.S. Allen et al., "Kinetics of the mucosal antibody secreting cell response and evidence of specific lymphocyte migration to the lung after oral immunisation with attenuated S-enterica var. typhimurium", FEMS IM MED, 27(4), 2000, pp. 275-281
4. Levine, MM
   Immunization against bacterial diseases of the intestine
   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
   
   M.M. Levine, "Immunization against bacterial diseases of the intestine", J PED GASTR, 31(4), 2000, pp. 336-355
5. CHAICUMPA W; CHONGSANGUAN M; KALAMBAHETI T; WILAIRATANA PA; SRIMANOTE P; MAKAKUNKIJCHAROEN Y; LOOAREESUWAN S; SAKOLVAREE Y
   IMMUNOGENICITY OF LIPOSOME-ASSOCIATED AND REFINED ANTIGEN ORAL CHOLERA VACCINES IN THAI VOLUNTEERS
   Vaccine
   
   W. Chaicumpa et al., "IMMUNOGENICITY OF LIPOSOME-ASSOCIATED AND REFINED ANTIGEN ORAL CHOLERA VACCINES IN THAI VOLUNTEERS", Vaccine, 16(7), 1998, pp. 678-684
6. KANTELE A
   PERIPHERAL-BLOOD ANTIBODY-SECRETING CELLS IN THE EVALUATION OF THE IMMUNE-RESPONSE TO AN ORAL VACCINE
   Journal of biotechnology
   
   A. Kantele, "PERIPHERAL-BLOOD ANTIBODY-SECRETING CELLS IN THE EVALUATION OF THE IMMUNE-RESPONSE TO AN ORAL VACCINE", Journal of biotechnology, 44(1-3), 1996, pp. 217-224
7. MCKENNA AJ; BYGRAVES JA; MAIDEN MCJ; FEAVERS IM
   ATTENUATED TYPHOID VACCINE SALMONELLA-TYPHI TY21A - FINGERPRINTING AND DUALITY CONTROL
   Microbiology
   
   A.J. Mckenna et al., "ATTENUATED TYPHOID VACCINE SALMONELLA-TYPHI TY21A - FINGERPRINTING AND DUALITY CONTROL", Microbiology, 141, 1995, pp. 1993-2002
8. FERGUSON A; SALLAM J; OMAHONY S; POXTON I
   CLINICAL INVESTIGATION OF GUT IMMUNE-RESPONSES
   Advanced drug delivery reviews
   
   A. Ferguson et al., "CLINICAL INVESTIGATION OF GUT IMMUNE-RESPONSES", Advanced drug delivery reviews, 18(1), 1995, pp. 53-71
9. VIRET JF; FAVRE D
   BIVALENT VACCINES AGAINST BACTERIAL ENTEROPATHOGENS - CONSTRUCTION OFLIVE ATTENUATED VACCINE STRAINS WITH 2 O-SEROTYPE SPECIFICITIES
   Biologicals
   
   J.F. Viret e D. Favre, "BIVALENT VACCINES AGAINST BACTERIAL ENTEROPATHOGENS - CONSTRUCTION OFLIVE ATTENUATED VACCINE STRAINS WITH 2 O-SEROTYPE SPECIFICITIES", Biologicals, 22(4), 1994, pp. 361-372
10. LINKAMSTER H; ROCHAT F; SAUDAN KY; MIGNOT O; AESCHLIMANN JM
    MODULATION OF A SPECIFIC HUMORAL IMMUNE-RESPONSE AND CHANGES IN INTESTINAL FLORA MEDIATED THROUGH FERMENTED MILK INTAKE
    FEMS immunology and medical microbiology
    
    H. Linkamster et al., "MODULATION OF A SPECIFIC HUMORAL IMMUNE-RESPONSE AND CHANGES IN INTESTINAL FLORA MEDIATED THROUGH FERMENTED MILK INTAKE", FEMS immunology and medical microbiology, 10(1), 1994, pp. 55-63
11. WALKER RI
    NEW STRATEGIES FOR USING MUCOSAL VACCINATION TO ACHIEVE MORE EFFECTIVE IMMUNIZATION
    Vaccine
    
    R.I. Walker, "NEW STRATEGIES FOR USING MUCOSAL VACCINATION TO ACHIEVE MORE EFFECTIVE IMMUNIZATION", Vaccine, 12(5), 1994, pp. 387-400
12. COHEN D; ASHKENAZI S; GREEN MS; YAVZORI M; ORR N; SLEPON R; LERMAN Y; ROBIN G; AMBAR R; BLOCK C; TAYLOR DN; HALE TL; SADOFF JC; WIENER M
    SAFETY AND IMMUNOGENICITY OF THE ORAL ESCHERICHIA-COLI K12 SHIGELLA-FLEXNERI 2A VACCINE (ECSF2A-2) AMONG ISRAELI SOLDIERS
    Vaccine
    
    D. Cohen et al., "SAFETY AND IMMUNOGENICITY OF THE ORAL ESCHERICHIA-COLI K12 SHIGELLA-FLEXNERI 2A VACCINE (ECSF2A-2) AMONG ISRAELI SOLDIERS", Vaccine, 12(15), 1994, pp. 1436-1442
13. KARNELL A; CAM PD; VERMA N; LINDBERG AA
    AROD DELETION ATTENUATES SHIGELLA-FLEXNERI STRAIN 2457T AND MAKES IT A SAFE AND EFFICACIOUS ORAL VACCINE IN MONKEYS
    Vaccine
    
    A. Karnell et al., "AROD DELETION ATTENUATES SHIGELLA-FLEXNERI STRAIN 2457T AND MAKES IT A SAFE AND EFFICACIOUS ORAL VACCINE IN MONKEYS", Vaccine, 11(8), 1993, pp. 830-836